CAPC researchers aim to improve the use of antibiotics in primary care
26 February 2016
New research led by Bristol NHS CCG and the University of Bristol, aimed at improving the quality of primary care for children with respiratory tract infections (RTIs) will be presented in London today (Feb 26th).
Carried out by the Centre for Academic Primary Care, the five-year TARGET programme included the largest and most rigorous set of studies of their kind. RTIs in children are the most common problem managed in primary care internationally. The programme, funded by the National Institute for Health Research Programme Grants for Applied Research Programme, was intended to give clinicians the tools they need to better care for these patients.
The programme found new evidence to help parents, primary care clinicians (doctors and nurses) and policy makers support improved antimicrobial stewardship in primary care.
The main findings of the five-year research programme are:
- Symptoms of respiratory tract infections in children last longer than many parents and clinicians expect (some for more than 21 days), and that this information is of great value to parents to help them know what to expect after seeing the doctor or nurse
- An important driver of antibiotic prescribing is clinical uncertainty - clinicians will adopt a "treat just in case" strategy when they are unsure if a child's condition could get worse (eg need hospitalisation) and they would welcome any evidence that helps them identify which children will get worse.
- Parents value consistent advice from a trusted source, which addresses their common concerns about their child’s RTI, and would value more advice about symptom relief and more precise safety netting advice.
- Experience and training in recognising severe RTIs, plus more evidence to identify the children at highest and lowest risk of illness deterioration, may help clinicians to identify children most and least likely to benefit from antibiotics.
- The most effective interventions to improve antibiotic use target parents and clinicians during consultations; promote clinician leadership in the intervention design; provide automatic prescribing prompts; and employ delayed prescribing.
Professor Alastair Hay, from the Centre for Academic Primary Care at the University of Bristol led the five-year TARGET Programme. He said: “Children with RTIs often receive antibiotics despite the fact that antibiotics will not help the majority of children’s infections. Our research has uncovered why clinicians prescribe antibiotics; what parents want from a consultation with their GP and what sorts of interventions would help improve the use of antibiotics in primary care. With antimicrobial resistance an ever growing problem, we hope our research will go some way to tackle this issue.”
As well as presenting their findings today, the researchers have launched two new websites to disseminate their findings:
- for clinicians and policymakers (bristol.ac.uk/target-ams)
Detailed information about the research including published papers
- for parents (Caring for children with cough, child-cough.bristol.ac.uk)
A guide for parents on when to see a GP and how to care for a child with a cough
This work presents independent research funded by the National Institute for Health Research (NIHR) Programme Grants for Applied Research Programme (Grant Reference Number RP-PG-0608-10018).
About the NIHR
The National Institute for Health Research (NIHR) is funded by the Department of Health to improve the health and wealth of the nation through research. The NIHR is the research arm of the NHS. Since its establishment in April 2006, the NIHR has transformed research in the NHS. It has increased the volume of applied health research for the benefit of patients and the public, driven faster translation of basic science discoveries into tangible benefits for patients and the economy, and developed and supported the people who conduct and contribute to applied health research. The NIHR plays a key role in the Government’s strategy for economic growth, attracting investment by the life-sciences industries through its world-class infrastructure for health research. Together, the NIHR people, programmes, centres of excellence, and systems represent the most integrated health research system in the world. For further information, visit the NIHR website (www.nihr.ac.uk).